---
ver: rpa2
title: OMG-RL:Offline Model-based Guided Reward Learning for Heparin Treatment
arxiv_id: '2409.13299'
source_url: https://arxiv.org/abs/2409.13299
tags:
- learning
- reward
- policy
- heparin
- treatment
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: The paper introduces Offline Model-based Guided Reward Learning
  (OMG-RL), a novel inverse reinforcement learning (IRL) approach designed for medication
  dosing, specifically targeting heparin treatment. The core idea is to learn a parameterized
  reward function directly from clinician dosing data, bypassing the need for manually
  defined clinical indicators.
---

# OMG-RL:Offline Model-based Guided Reward Learning for Heparin Treatment

## Quick Facts
- arXiv ID: 2409.13299
- Source URL: https://arxiv.org/abs/2409.13299
- Reference count: 4
- One-line primary result: OMG-RL learns a parameterized reward function from clinician dosing data, achieving treatment success rates comparable to model-based methods and superior to model-free approaches for heparin therapy.

## Executive Summary
This paper introduces Offline Model-based Guided Reward Learning (OMG-RL), a novel inverse reinforcement learning approach designed for medication dosing, specifically targeting heparin treatment. The core idea is to learn a parameterized reward function directly from clinician dosing data, bypassing the need for manually defined clinical indicators. OMG-RL employs a dynamic model to handle state transitions and uses a guided reward approach to maximize entropy, aligning the learned policy with expert intentions. The method is validated on a dataset from the MIMIC-III database, demonstrating that OMG-RL effectively improves treatment success rates compared to traditional methods.

## Method Summary
OMG-RL is an offline inverse reinforcement learning approach that learns a parameterized reward function from clinician dosing data to guide heparin treatment policies. The method uses a probabilistic dynamic model trained on batch data to generate synthetic rollouts, which augment the training distribution. A reward network is optimized using maximum entropy IRL with guided reward learning, while a Q-function is updated conservatively to penalize out-of-distribution states. The policy is improved using Soft Actor-Critic updates, with the learned reward function guiding decision-making. The approach is evaluated on the MIMIC-III database, demonstrating improved treatment success rates compared to model-free methods.

## Key Results
- OMG-RL achieves a treatment success rate of approximately 0.60, comparable to model-based approaches and superior to model-free methods.
- The learned reward function closely mirrors clinically defined rewards based on aPTT therapeutic ranges, confirming effective capture of clinical decision-making.
- The dynamic model-based rollouts positively influence policy reinforcement, expanding the agent's experience beyond the limited offline dataset.

## Why This Works (Mechanism)

### Mechanism 1
- Claim: The model-based approach with dynamic rollout expands the agent's experience beyond the limited offline dataset, improving policy generalization.
- Mechanism: A probabilistic dynamic model (ÃÇùëá(ùë†‚Ä≤, ùëü|ùë†, ùëé)) is trained on the batch data to simulate transitions. Dyna-style rollouts generate synthetic state-action-reward tuples, which are added to the replay buffer alongside real data. This augments the effective training distribution, enabling the policy to learn from a broader state-action space than is present in the original dataset.
- Core assumption: The learned dynamic model accurately captures the underlying transition dynamics well enough that rollouts remain informative and do not mislead the policy into unsafe or invalid regions.
- Evidence anchors:
  - [section] "Utilizing the clinical dataset and the dynamic model, we trained COMBO over 500 episodes and calculated the mean and standard deviation of test returns and test Q-values across a total of ten experiments."
  - [section] "These findings confirm that exploration and exploitation via the dynamic model positively influence the reinforcement of the agent's policy."
  - [corpus] Weak: no direct comparative study on rollout quality in this paper, but COMBO methodology supports the claim.
- Break condition: If the dynamic model is poorly trained (high prediction error), rollouts will introduce bias and degrade policy performance, especially in out-of-distribution states.

### Mechanism 2
- Claim: Conservative Q-value updates penalize overestimation in out-of-distribution states, stabilizing learning in offline settings.
- Mechanism: The recursive Q-update includes a penalty term weighted by Œ± that minimizes Q-values for state-action pairs drawn from the sampling distribution œÅ(s,a), which is based on the dynamic model. This discourages the policy from relying on potentially incorrect transitions while allowing Q-values for trusted batch data to be reinforced.
- Core assumption: The model's uncertainty can be sufficiently approximated by comparing the sampling distribution from the model against the empirical batch distribution, allowing for meaningful penalization.
- Evidence anchors:
  - [section] "To ensure conservative policy updates, we penalize the Q-values for state-action pairs that likely deviate from the expected distribution and adjust Q-values for reliable pairs."
  - [section] "This approach penalizes out-of-distribution states generated during dynamic model simulations (rollouts), thereby leveraging the generalization advantages of model-based algorithms while avoiding the limitations imposed by uncertainty quantification."
- Break condition: If Œ± is set too high, the policy becomes overly conservative and fails to learn; if too low, the benefit of conservatism is lost.

### Mechanism 3
- Claim: Guided reward learning via maximum entropy IRL aligns the learned reward function with expert clinician behavior, improving policy alignment with clinical intentions.
- Mechanism: The reward network is trained using sample-based optimization of the log-likelihood of expert trajectories under the current policy. By maximizing entropy, the learned reward function captures broader expert behavior rather than fitting to a few predefined indicators. This reward is then used to guide policy updates.
- Core assumption: Expert trajectories in the MIMIC-III dataset represent sub-optimal but meaningful clinician decisions that can be used to infer reward structure without explicit clinical indicators.
- Evidence anchors:
  - [abstract] "Through OMG-RL, we learn a parameterized reward function that captures the expert's intentions from limited data, thereby enhancing the agent's policy."
  - [section] "The sample trajectory generated by the dynamic model is used to enhance the agent's policy and estimate the partition function of the reward function."
- Break condition: If the expert data is too noisy or inconsistent, the inferred reward function may misrepresent true clinical intent, leading to suboptimal policies.

## Foundational Learning

- Concept: Markov Decision Process (MDP)
  - Why needed here: The RL framework is defined over states, actions, rewards, and transitions. Understanding the MDP tuple is essential to see how the policy interacts with the environment and how rewards shape behavior.
  - Quick check question: In the MDP formulation, what does the transition function P(s', r | s, a) represent?
- Concept: Maximum Entropy IRL
  - Why needed here: This is the core learning mechanism for the reward function. It allows the agent to infer clinician intentions from observed trajectories rather than relying on manually defined rewards.
  - Quick check question: What is the role of the partition function Z in maximum entropy IRL?
- Concept: Importance Sampling
  - Why needed here: Used in the guided reward loss to correct for bias when estimating expectations over the policy distribution, ensuring consistent reward estimation.
  - Quick check question: Why is importance sampling necessary when computing the gradient of the reward loss in guided reward learning?

## Architecture Onboarding

- Component map: Dynamic Model -> Reward Network -> Q-function -> Policy
- Critical path:
  1. Train dynamic model on batch data
  2. Initialize policy and reward network
  3. For each epoch:
     - Generate rollouts using dynamic model
     - Update reward network using guided reward loss
     - Update Q-function conservatively
     - Improve policy using updated Q-function
- Design tradeoffs:
  - Ensemble size vs. computational cost in dynamic model
  - Œ± penalty weight vs. policy conservatism
  - Rollout horizon vs. divergence risk in simulated trajectories
- Failure signatures:
  - Reward function diverging (exploding values)
  - Q-values collapsing to zero due to excessive conservatism
  - Dynamic model predictions drifting far from real data
- First 3 experiments:
  1. Train dynamic model and evaluate prediction error on held-out data
  2. Run OMG-RL with fixed reward function (ùëüùëù) to verify policy improvement
  3. Train reward network alone with expert trajectories and inspect learned reward patterns against ùëüùëù

## Open Questions the Paper Calls Out

### Open Question 1
- Question: How does the performance of OMG-RL compare when applied to continuous action spaces for medication dosing tasks?
- Basis in paper: [inferred] The paper mentions that the discrete action space used in the experiments contrasts with the continuous variables typically encountered in medication dosing.
- Why unresolved: The study used a discrete action space, and the authors suggest that future research should explore models that accommodate continuous action frameworks to enhance predictive accuracy.
- What evidence would resolve it: Experiments comparing OMG-RL's performance on tasks with continuous action spaces versus discrete ones would provide insight into its adaptability and effectiveness in real-world clinical settings.

### Open Question 2
- Question: How generalizable is OMG-RL across different patient demographics and geographic regions?
- Basis in paper: [inferred] The authors note the need for additional empirical validation across broader demographic and geographic patient datasets to ensure generalizability and applicability in real-world clinical settings.
- Why unresolved: The study primarily used data from the MIMIC-III database, which may not represent all patient demographics or geographic regions.
- What evidence would resolve it: Conducting experiments using diverse patient datasets from various regions and demographics would help determine OMG-RL's generalizability and effectiveness across different populations.

### Open Question 3
- Question: How does OMG-RL perform compared to other IRL methods in offline settings for medication dosing tasks?
- Basis in paper: [explicit] The paper introduces OMG-RL as a novel IRL approach and compares its performance with model-based and model-free approaches, but does not compare it to other IRL methods.
- Why unresolved: The study focuses on validating OMG-RL's effectiveness but does not explore its performance relative to other IRL methods in offline settings.
- What evidence would resolve it: Comparative experiments between OMG-RL and other IRL methods in offline settings would provide insights into its relative performance and potential advantages or limitations.

## Limitations
- The robustness of the dynamic model's predictions is not extensively validated against real-world rollouts, raising concerns about policy generalization.
- The study relies on expert clinician behavior in the MIMIC-III dataset, which may contain sub-optimal or inconsistent dosing decisions, potentially limiting the fidelity of the learned reward function.
- The absence of ablation studies comparing OMG-RL with alternative reward learning methods makes it difficult to isolate the contribution of the maximum entropy guided reward approach.

## Confidence
- High confidence: The offline RL framework design and conservative Q-learning implementation align with established methods like COMBO.
- Medium confidence: The guided reward learning mechanism's ability to capture expert intent is supported by alignment with clinically defined rewards but lacks comparative ablation studies.
- Low confidence: The dynamic model's reliability for generating synthetic rollouts is uncertain due to limited validation of rollout quality and no explicit analysis of model bias or divergence.

## Next Checks
1. Conduct an ablation study comparing OMG-RL's reward learning performance against baseline methods such as supervised reward regression or behavioral cloning, using the same MIMIC-III dataset and policy evaluation metrics.
2. Evaluate the dynamic model's prediction accuracy on a held-out test set and analyze the distribution of rollout states to quantify model bias and potential divergence from real data.
3. Perform out-of-distribution safety analysis by testing the learned policy on synthetic patient states not present in the MIMIC-III training data, measuring both reward performance and adherence to clinically safe dosing ranges.